Zunveyl is a next-generation acetylcholinesterase inhibitor approved in the U.S. for mild-to-moderate Alzheimer's disease.

A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...

Learn how targeted hip-opening exercises can boost flexibility, reduce chronic pain, and improve mobility patterns for better ...